Showing results (161-170 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|January 14, 2020
Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysisNasser Alkhushaym, Abdulaali R Almutairi, Abdulhamid Althagafi, et al.Expert Opinion on Drug Safety|December 19, 2019
The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritisAlen Zabotti, Delia Goletti, Ennio Lubrano, et al.Expert Opinion on Drug Safety|November 3, 2020
Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting systemZahid Ali, Mohammad Ismail, Fahadullah Khan, et al.Expert Opinion on Drug Safety|January 18, 2018
An update on the safety of nutraceuticals and effects on lipid parametersArrigo F G Cicero, Alessandro CollettiExpert Opinion on Drug Safety|October 22, 2020
Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needsCharlotte Höybye, Paolo Beck-Peccoz, Suat Simsek, et al.Expert Opinion on Drug Safety|November 12, 2020
Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventionsMattia Galli, Davide Capodanno, Felicita Andreotti, et al.Expert Opinion on Drug Safety|November 10, 2020
Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese pharmacovigilance systemCristina Monteiro, Ana Paula Duarte, Gilberto AlvesExpert Opinion on Drug Safety|September 7, 2020
Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic reviewFelice Iasevoli, Annarita Barone, Elisabetta Filomena Buonaguro, et al.Expert Opinion on Drug Safety|September 7, 2020
Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonatesKashif Hussain, Muhammad Sohail Salat, Gul Ambreen, et al.Expert Opinion on Drug Safety|September 29, 2020
Safety of current therapies for onychomycosisJose W Ricardo, Shari R LipnerPageof 281